Arcus Biosciences, Inc. (RCUS)

Last Closing Price: 15.76 (2026-11-18)

EBIT (Quarterly)

EBIT: Income before interest and taxes.

Arcus Biosciences, Inc. (RCUS) had EBIT of $-131.00M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$9.00M
$-128.00M
--
$9.00M
$140.00M
$-131.00M
$3.00M
$-128.00M
$-128.00M
$-128.00M
$-128.00M
$-128.00M
$-128.00M
EBIT
$-131.00M
$-131.00M
127.40M
127.40M
$-1.00
$-1.00
Balance Sheet Financials
$664.00M
$33.00M
$154.00M
$818.00M
$199.00M
$102.00M
$261.00M
$460.00M
$358.00M
$358.00M
$358.00M
127.60M
Cash Flow Statement Financials
$-345.00M
$248.00M
$26.00M
$225.00M
$154.00M
$-71.00M
$50.00M
--
--
Fundamental Metrics & Ratios
3.34
--
--
0.22
0.28
100.00%
-1455.56%
-1455.56%
--
-1422.22%
-1422.22%
$-345.00M
--
--
--
0.01
--
0.50
180.00
-35.75%
-35.75%
-15.65%
-27.83%
$2.81
$-2.71
$-2.71